Inhibition of constitutive Akt (PKB) phosphorylation by docosahexaenoic acid in the human breast cancer cell line MDA-MB-453

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 2, 2013, Pages 306-313

  Sato, Satoshi B ^a   Park, Jungha ^a   Kawamoto, Jun ^b   Sato, Sho ^b   Kurihara, Tatsuo ^b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Akt; Breast cancer; Docosahexaenoic acids; Fatty acids; Polyunsaturated fatty acids

Indexed keywords

2,4 DIENOYL COENZYME A REDUCTASE (NADPH); DNA DEPENDENT PROTEIN KINASE; DOCOSAHEXAENOIC ACID; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CATALYSIS; CELL PROLIFERATION; CONTROLLED STUDY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; DOCOSAHEXAENOIC ACIDS; FEMALE; HUMANS; PHOSPHORYLATION; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84868563766     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.10.004     Document Type: Article

References (55)

1. B.D. Manning, and L.C. Cantley AKT/PKB signaling: navigating downstream Cell 129 2007 1261 1274
2. R.L. Dillon, D.E. White, and W.J. Muller The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer Oncogene 26 2007 1338 1345
3. R. Zoncu, A. Efeyan, and D.M. Sabatini mTOR: from growth signal integration to cancer, diabetes and ageing Nat. Rev. Mol. Cell Biol. 12 2011 21 35
4. J.A. Engelman Targeting PI3K signaling in cancer: opportunities, challenges and limitations Nat. Rev. Cancer 9 2009 550 562
5. K.G. Foster, and D.C. Fingar Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony J. Biol. Chem. 285 2010 14071 14077
6. P. Liu, H. Cheng, T.M. Roberts, and J.J. Zhao Targeting the phosphoinositide 3-kinase pathway in cancer Nat. Rev. Drug Discov. 8 2009 627 644
7. N.E. Hynes, and G. MacDonald ErbB receptors and signaling pathways in cancer Curr. Opin. Cell Biol. 21 2009 177 184
8. V.P. Eswarakumar, I. Lax, and J. Schlessinger Cellular signaling by fibroblast growth factor receptors Cytokine Growth Factor Rev. 16 2005 139 149
9. D. LeRoith, and C.T. Roberts Jr. The insulin-like growth factor system and cancer Cancer Lett. 195 2003 127 137
10. J. Park, J. Feng, Y. Li, O. Hammarsten, D.P. Brazil, and B.A. Hemmings DNA-dependent protein kinase-mediated phosphorylation of protein kinase B requires a specific recognition sequence in the C-terminal hydrophobic motif J. Biol. Chem. 284 2009 6169 6174
11. C.V. Hinton, S. Avraham, and H.K. Avraham Contributions of integrin-linked kinase to breast cancer metastasis and tumourigenesis J. Cell. Mol. Med. 12 2008 1517 1526
12. P.P. Hsu, S.A. Kang, J. Rameseder, Y. Zhang, K.A. Ottina, D. Lim, T.R. Peterson, Y. Choi, N.S. Gray, M.B. Yaffe, J.A. Marto, and D.M. Sabatini The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling Science 332 2011 1317 1322
13. Y. Yu, S.O. Yoon, G. Poulogiannis, Q. Yang, X.M. Ma, J. Villén, N. Kubica, G.R. Hoffman, L.C. Cantley, S.P. Gygi, and J. Blenis Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling Science 332 2011 1322 1326
14. A. Carracedo, L. Ma, J. Teruya-Feldstein, F. Rojo, L. Salmena, A. Alimonti, A. Egia, A.T. Sasaki, G. Thomas, S.C. Kozma, A. Papa, C. Nardella, L.C. Cantley, J. Baselga, and P.P. Pandolfi Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer J. Clin. Invest. 118 2008 3065 3074
15. C.A. Sparks, and D.A. Guertin Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy Oncogene 29 2010 3733 3744
16. P. Bougnoux, N. Hajjaji, K. Maheo, C. Couet, and S. Chevalier Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth Prog. Lipid Res. 49 2010 76 86
17. S.C. Larsson, M. Kumlin, M. Ingelman-Sundberg, and A. Wolk Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms Am. J. Clin. Nutr. 79 2004 935 945
18. I.M. Berquin, I.J. Edwards, and Y.Q. Chen Multi-targeted therapy of cancer by omega-3 fatty acids Cancer Lett. 269 2008 363 377
19. C.H. Jakobsen, G.L. Størvold, H. Bremseth, T. Follestad, K. Sand, M. Mack, K.S. Olsen, A.G. Lundemo, J.G. Iversen, H.E. Krokan, and S.A. Schønberg DHA induces ER stress and growth arrest in human colon cancer cells: associations with cholesterol and calcium homeostasis J. Lipid Res. 49 2008 2089 2100
20. P.D. Schley, H.B. Jijon, L.E. Robinson, and C.J. Field Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells Breast Cancer Res. Treat. 92 2005 187 195
21. K.R. Rogers, K.D. Kikawa, M. Mouradian, K. Hernandez, K.M. McKinnon, S.M. Ahwah, and R.S. Pardini Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association Carcinogenesis 31 2010 1523 1530
22. E.D. Collett, L.A. Davidson, Y.Y. Fan, J.R. Lupton, and R.S. Chapkin n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes Am. J. Physiol. Cell Physiol. 280 2001 C1066 C1075
23. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 2009 1029 1033
24. S.J. Miller, X. Xing, L. Xi, and M.C. Hung Identification of a specific DNA region required for enhanced transcription of HER2/neu in the MDA-MB-453 breast cancer cell line DNA Cell Biol. 15 1996 749 757
25. H. Shimizu, N. Koyama, M. Asada, and K. Yoshimatsu Aberrant expression of integrin and erbB subunits in breast cancer cell lines Int. J. Oncol. 21 2002 1073 1079
26. A. Roidl, P. Foo, W. Wong, C. Mann, S. Bechtold, H.J. Berger, S. Streit, J.E. Ruhe, S. Hart, A. Ullrich, and H.K. Ho The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB-453 breast cancer cells Oncogene 29 2010 1543 1552
27. E.A. Oldham, C. Li, S. Ke, S. Wallace, and P. Huang Comparison of action of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in human breast cancer cells Int. J. Oncol. 16 2000 125 132
28. D.J. Venter, S.J. Ramus, F.M. Hammet, M. de Silva, A.M. Hutchins, V. Petrovic, G. Price, and J.E. Armes Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines Cancer Genet. Cytogenet. 160 2005 134 140
29. J.A. Lalman, and D.M. Bagley Extracting long-chain fatty acids from a fermentation medium J. Am. Oil Chem. Soc. 81 2004 105 110
30. M.Y. Golovko, and E.J. Murphy An improved method for tissue long-chain acyl-CoA extraction and analysis J. Lipid Res. 45 2004 1777 1782
31. W.R. Morrison, and L.M. Smith Preparation of fatty acid methyl esters and dimethyacetals from lipids with boron fluoride-methanol J. Lipid Res. 5 1964 600 608
32. D. DeFeo-Jones, S.F. Barnett, S. Fu, P.J. Hancock, K.M. Haskell, K.R. Leander, E. McAvoy, R.G. Robinson, M.E. Duggan, C.W. Lindsley, Z. Zhao, H.E. Huber, and R.E. Jones Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members Mol. Cancer Ther. 4 2005 271 279
33. V. Calleja, M. Laguerre, P.J. Parker, and B. Larijani Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition PLoS Biol. 7 2009 e17
34. J. Ursini-Siegel, A.B. Rajput, H. Lu, V. Sanguin-Gendreau, D. Zuo, V. Papavasiliou, C. Lavoie, J. Turpin, K. Cianflone, D.G. Huntsman, and W.J. Muller Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development Mol. Cell. Biol. 27 2007 6361 6371
35. R.I. Feldman, J.M. Wu, M.A. Polokoff, M.J. Kochanny, H. Dinter, D. Zhu, S.L. Biroc, B. Alicke, J. Bryant, S. Yuan, B.O. Buckman, D. Lentz, M. Ferrer, M. Whitlow, M. Adler, S. Finster, Z. Chang, and D.O. Arnaiz Novel small molecule inhibitors of 3-phosphoinositide- dependent kinase-1 J. Biol. Chem. 280 2005 19867 19874
36. J.M. García-Martínez, J. Moran, R.G. Clarke, A. Gray, S.C. Cosulich, C.M. Chresta, and D.R. Alessi Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR) Biochem. J. 421 2009 29 42
37. Y. Zhao, H.D. Thomas, M.A. Batey, I.G. Cowell, C.J. Richardson, R.J. Griffin, A.H. Calvert, D.R. Newell, G.C. Smith, and N.J. Curtin Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441 Cancer Res. 66 2006 5354 5362
38. A.A. Troussard, P.C. McDonald, E.D. Wederell, N.M. Mawji, N.R. Filipenko, K.A. Gelmon, J.E. Kucab, S.E. Dunn, J.T. Emerman, M.B. Bally, and S. Dedhar Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival Cancer Res. 66 2006 393 403
39. J. Kalra, C. Warburton, K. Fang, L. Edwards, T. Daynard, D. Waterhouse, W. Dragowska, B.W. Sutherland, S. Dedhar, K. Gelmon, and M. Bally QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model Breast Cancer Res. 11 2009 R25
40. S.B. Sato, S. Sato, J. Kawamoto, and T. Kurihara Differential roles of internal and terminal double bonds in docosahexaenoic acid: Comparative study of cytotoxicity of polyunsaturated fatty acids to HT-29 human colorectal tumor cell line Prostaglandins Leukot. Essent. Fatty Acids 84 2011 31 37
41. G.T. Vatassery, E.M. Krezowsky, and J.H. Eckfeldt Vitamin E concentrations in human blood plasma and platelets Am. J. Clin. Nutr. 37 1983 1020 1024
42. Y. Kosugi, C. Quinglong, K. Kanazawa, and H. Nakanishi Changes in hydrolysis specificities of lipase from Rhizomucor miehei to polyunsaturated fatty acyl esters in different aggregation states J. Am. Oil Chem. Soc. 74 1997 1395 1399
43. R.E. Teresi, and K.A. Waite PPARgamma, PTEN, and the fight against cancer PPAR Res. 2008 2008 932632
44. T.M. Covey, K. Edes, and F.A. Fitzpatrick Akt activation by arachidonic acid metabolism occurs via oxidation and inactivation of PTEN tumor suppressor Oncogene 26 2007 5784 5792
45. X.Z. Ding, W.G. Tong, and T.E. Adrian Multiple signal pathways are involved in the mitogenic effect of 5(S)-HETE in human pancreatic cancer Oncology 65 2003 285 294
46. X. Gao, P.R. Lowry, X. Zhou, C. Depry, Z. Wei, G.W. Wong, and J. Zhang PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains Proc. Natl. Acad. Sci. U. S. A. 108 2011 14509 14514
47. D. Berchtold, and T.C. Walther TORC2 plasma membrane localization is essential for cell viability and restricted to a distinct domain Mol. Biol. Cell 20 2009 1565 1575
48. C. Partovian, R. Ju, Z.W. Zhuang, K.A. Martin, and M. Simons Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells Mol. Cell 32 2008 140 149
49. H. Lucero, D. Gae, and G.E. Taccioli Novel localization of the DNA-PK complex in lipid rafts: a putative role in the signal transduction pathway of the ionizing radiation response J. Biol. Chem. 278 2003 22136 22143
50. K.R. Legate, E. Montañez, O. Kudlacek, and R. Fässler ILK, PINCH and parvin: the tIPP of integrin signaling Nat. Rev. Mol. Cell Biol. 7 2006 20 31
51. Y.V. Shulga, D.S. Myers, P.T. Ivanova, S.B. Milne, H.A. Brown, M.K. Topham, and R.M. Epand Molecular species of phosphatidylinositol-cycle intermediates in the endoplasmic reticulum and plasma membrane Biochemistry 49 2010 312 317
52. J. Cai, H. Abramovici, S.H. Gee, and M.K. Topham Diacylglycerol kinases as sources of phosphatidic acid Biochim. Biophys. Acta 1791 2009 942 948
53. M.K. Topham, and R.M. Epand Mammalian diacylglycerol kinases: molecular interactions and biological functions of selected isoforms Biochim. Biophys. Acta 1790 2009 416 424
54. A. Toschi, E. Lee, L. Xu, A. Garcia, N. Gadir, and D.A. Foster Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin Mol. Cell. Biol. 29 2009 1411 1420
55. C. Calzada, R. Colas, N. Guillot, M. Guichardant, M. Laville, E. Véricel, and M. Lagarde Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men Atherosclerosis 208 2010 467 472